|
|
|
|
 |
 |
Spanning Disciplines, Advancing Knowledge Promoting Awareness, Progress, and Applications of the Human Genome Project |
Sponsored by the U.S. Department of Energy Human Genome Program
Human
Genome News Archive Edition |
| Available in PDF In this issue... DOE '99 Oakland Highlights Genome Project In the News Microbial Genomics Ethical, Legal, and Social Issues Informatics Web, Other Resources, Publications Funding Meeting Calendars & Acronyms |
Genome ProjectJGI Refits Production Sequencing Facility
JGI's current sequencing targets are human chromosomes 5, 16, and 19, which together contain about 300 Mb of DNA or about 10% of the entire human genome. Sequencing director Trevor Hawkins reports that as of September20, JGI had produced 31.2 Mb of finished sequence and about 41Mb of draft sequence (see "HGP Sequencing Progress"). The Genome Annotation Consortium is joining with JGI for sequence analysis (see "Informatics" for details), and Stanford University will be part of the finishing effort. The electronic form of the newsletter may be cited in the following
style: |
Last modified: Wednesday, October 29, 2003
Home * Contacts * Disclaimer
Document Use and Credits
Publications and webpages on this site were created by the U.S. Department of Energy Genome Program's Biological and Environmental Research Information System (BERIS). Permission to use these documents is not needed, but please credit the U.S. Department of Energy Genome Programs and provide the website http://genomics.energy.gov. All other materials were provided by third parties and not created by the U.S. Department of Energy. You must contact the person listed in the citation before using those documents.
Base URL: www.ornl.gov/hgmis
Site sponsored by the U.S. Department of Energy
Office of Science, Office
of Biological and Environmental Research, Human
Genome Program
Accelerated goals are challenging the major Human Genome Project sequencing centers to restructure and streamline their processes. The Joint Genome Institute (JGI) Production Sequencing Facility is using 84 new high-throughput MegaBACE DNA sequencing machines acquired from Amersham Pharmacia Biotech. These machines use multiple thin "capillary" tubes instead of large flat gels to separate and "read" the DNA sequence. The technology was developed largely with funding from the DOE Human Genome Program and licensed to AP Biotech.